Format

Send to

Choose Destination
Calcif Tissue Int. 2019 Mar;104(3):235-238. doi: 10.1007/s00223-018-00512-x.

Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Author information

1
Centre for Metabolic Bone Diseases, University of Sheffield, University of Sheffield Medical School, Sheffield, UK.
2
Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
3
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
4
NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK.
5
Service of Bone Diseases, Faculty of Medicine of Geneva, Geneva University Hospitals, 1211, Geneva 14, Switzerland. Rene.Rizzoli@unige.ch.
6
Prince Mutaib Chair for Biomarkers, College of Science, King Saud University, Riyadh, Saudi Arabia.
7
Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.

Abstract

A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis was recently published in Osteoporosis International as a joint effort of the International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (Kanis et al. in Osteoporos Int https://doi.org/10.1007/s00198-018-4704-5 , 2018). This manuscript updates the previous guidelines document, published in 2013 (Kanis et al. in Osteoporos Int 24:23-57, 2013) and is written in a European perspective. The present article reports and summarizes the main recommendations included in this 2018 guidance document.

KEYWORDS:

Bone mineral density; Diagnosis of osteoporosis; FRAX; Fracture risk assessment; Health economics; Treatment of osteoporosis

PMID:
30796490
DOI:
10.1007/s00223-018-00512-x

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center